Author:
Tembhre Manoj Kumar,Chawla Mehma Kaur,Berthiaume Francois,Kumar Suneel
Reference97 articles.
1. Allegretti JR, Mullish BH, Kelly C, Fischer M (2019) The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications. Lancet Lond Engl 394(10196):420–431
2. AOBiome (n.d.) Therapeutics reports positive efficacy results from Phase 2b clinical trial of ammonia oxidizing bacteria (AOB) for the treatment of acne vulgaris [Internet]. AOBiome. [cited 2019 Oct 20]. https://www.aobiome.com/pressreleases/aobiome-therapeutics-reports-positive-efficacy-results-from-phase-2b-clinical-trial-of-ammonia-oxidizing-bacteria-aob-for-the-treatment-of-acne-vulgaris/
3. Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan T-J et al (2012) Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 338(6103):120–123
4. Baquero F, Nombela C (2012) The microbiome as a human organ. Clin Microbiol Infect 18(s4):2–4
5. Belkaid Y, Hand TW (2014) Role of the microbiota in immunity and inflammation. Cell 157(1):121–141
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献